Global life sciences risk report 2024 : How the industry perceives emerging risks and challenges

<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
  <record>
    <leader>00000cam a22000004b 4500</leader>
    <controlfield tag="001">MAP20240010898</controlfield>
    <controlfield tag="003">MAP</controlfield>
    <controlfield tag="005">20240704121200.0</controlfield>
    <controlfield tag="008">230315s2024    gbr||||       ||| ||eng d</controlfield>
    <datafield tag="040" ind1=" " ind2=" ">
      <subfield code="a">MAP</subfield>
      <subfield code="b">spa</subfield>
      <subfield code="d">MAP</subfield>
    </datafield>
    <datafield tag="084" ind1=" " ind2=" ">
      <subfield code="a">7</subfield>
    </datafield>
    <datafield tag="245" ind1="1" ind2="0">
      <subfield code="a">Global life sciences risk report 2024</subfield>
      <subfield code="b">: How the industry perceives emerging risks and challenges</subfield>
    </datafield>
    <datafield tag="260" ind1=" " ind2=" ">
      <subfield code="a">London</subfield>
      <subfield code="b">Willis Towers Watson</subfield>
      <subfield code="c">2024</subfield>
    </datafield>
    <datafield tag="300" ind1=" " ind2=" ">
      <subfield code="a">24 p.</subfield>
    </datafield>
    <datafield tag="520" ind1=" " ind2=" ">
      <subfield code="a">The life science sector has experienced rapid evolution in recent years, driven by scientific breakthroughs in areas such as gene and cell therapies, biologics and new vaccines. However, this swift progress has also brought challenges. Some innovations have not lived up to their initial promise, and concerns about the high costs of drug development have grown. Additionally, companies are struggling to find individuals with the specialized skills they need. In our second Life Science global survey, we asked 400 senior decision-makers about their perspectives on this changing landscape. We explored their views on the main risks and opportunities, how they are managing emerging challenges, and their plans for the future</subfield>
    </datafield>
    <datafield tag="522" ind1=" " ind2=" ">
      <subfield code="a">Internacional</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20100037607</subfield>
      <subfield code="a">Ciencias de la salud</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080591182</subfield>
      <subfield code="a">Gerencia de riesgos</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20100017982</subfield>
      <subfield code="a">Riesgos emergentes</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20170006503</subfield>
      <subfield code="a">Transformación digital</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080606787</subfield>
      <subfield code="a">Innovación empresarial</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20120019492</subfield>
      <subfield code="a">Tendencias</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080585266</subfield>
      <subfield code="a">Factores de riesgo</subfield>
    </datafield>
    <datafield tag="650" ind1=" " ind2="4">
      <subfield code="0">MAPA20080550592</subfield>
      <subfield code="a">Encuestas</subfield>
    </datafield>
    <datafield tag="710" ind1="2" ind2=" ">
      <subfield code="0">MAPA20170016144</subfield>
      <subfield code="a">Willis Towers Watson</subfield>
    </datafield>
    <datafield tag="787" ind1="0" ind2=" ">
      <subfield code="w">MAP20230004678</subfield>
      <subfield code="t">Global life sciences risk outlook 2023. Managing emerging risks, challenges and opportunities in the life science sector : WTW global life science survey</subfield>
      <subfield code="d">London : Willis Towers Watson, 2022</subfield>
    </datafield>
    <datafield tag="856" ind1=" " ind2=" ">
      <subfield code="u">https://www.wtwco.com/en-us/insights/2024/06/global-life-science-risk-report-2024</subfield>
    </datafield>
  </record>
</collection>